Fulcrum Therapeutics, Inc. (FULC)
12.28
+0.12
(+0.99%)
USD |
NASDAQ |
Dec 19, 16:00
12.28
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Shareholders Equity (Annual): 243.03M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Agios Pharmaceuticals, Inc. | 1.541B |
| Biogen, Inc. | 16.72B |
| CorMedix, Inc. | 84.66M |
| Apellis Pharmaceuticals, Inc. | 228.54M |
| NovaBay Pharmaceuticals, Inc. | -0.129M |